Missouri Innovation Center

Where Missouri technology companies start and scale

MIC gives founders the lab space, risk capital, expertise, and a university network
needed to build high-growth science and technology companies.

Get in touch
200+
Startups Supported
$850M+
Capital Raised by MIC Companies
1,000+
Jobs Created
What MIC Provides

Everything founders need to move
from research to company scale

MIC combines startup-ready infrastructure, capital access, operating support,
and the Mizzou network in one company-building platform.

01

Lab & Office Space

Wet labs, coworking, offices, and shared infrastructure allow companies to start lean and expand as milestones are met.

02

Capital

MIC investment activity and the Centennial Investors angel network connect founders to early capital and follow-on syndicates.

03

Expertise

Executives, mentors, and technical advisors support company formation, commercialization, hiring, and federal grant strategy, from SBIR positioning through award.

04

Network

Founders can access Mizzou research capabilities, core facilities, technical talent, and a building full of other science and technology founders, advisors, and investors.

Charlie Bolten, President & CEO of Missouri Innovation Center
From the CEO

Mizzou has the research engine, Columbia has the founder energy, and MIC connects both into companies that can scale.

Charlie Bolten President & CEO, Missouri Innovation Center · Read his story →
Current builders at MIC
Recent News

What is happening at MIC and our companies

Capital raises, company milestones, partnerships,
and the people building Missouri technology companies

News · April 2026

ABK Biomedical plans Ashland manufacturing facility

ABK Biomedical and COR Development announced plans for a commercial GMP manufacturing facility in Ashland, near MURR and the yttrium-90 supply chain for ABK's Eye90 therapy.

Read at PR Newswire →
News · March 2026

Endevica Bio spins out Kalohexis

Endevica Bio launched Kalohexis to advance melanocortin therapies for obesity and metabolic disease while Endevica continues its Phase 2 cancer cachexia program.

Read at Endevica Bio →
News · December 2025

Charlie Bolten on MIC, Mizzou, and Mid-Missouri innovation

COMO Business Times profiled Charlie Bolten and his vision for connecting Mizzou research, founder talent, and company formation in Mid-Missouri.

Read at COMO Business Times →

Ready to build at MIC?

Bring the company, the technology, or the research problem. MIC can help define the path from first experiment to fundable venture.

Start the Conversation →